Dr. Hosford-Dunn began blogging in her audiology private practice in Tucson, AZ. Back in 2009, blogging was a new and interesting way to quickly share and improve information with colleagues, consumers, and patients. As blogging gained attention, she had the opportunity to serve as chief editor of a multi-author blog for an hearing industry publication. The format was fun and successful. It rapidly evolved into Hearing Health & Technology Matters! (HHTM), an independent blogsite that she founded in partnership with other colleagues in 2011. Since its inception, Dr. Hosford-Dunn has served as HHTM’s first Editor-in-Chief, then Managing Editor, and now is CFO of the organization. After graduating with a BA and MA in Communication Disorders from New Mexico State, she completed a PhD in Hearing Sciences at Stanford and did post-docs at Max Planck Institute (Germany) and Eaton-Peabody Auditory Physiology Lab (Boston). Post-education, she directed the Stanford University Audiology Clinic; developed multi-office private practices in Arizona; authored/edited numerous text books, chapters, journals, and articles; and taught Marketing, Practice Management, Hearing Science, Auditory Electrophysiology, and Amplification in a variety of academic settings. Dr. Hosford-Dunn participates in life long learning by writing weekly posts and by embracing sequential learning endeavors. She spent a year training with the Gemological Institute of America, gaining certification as a Graduate Gemologist (GIA). She graduated with a B.A. in Economics and Psychology from the University of Arizona in 2013. Currently — and probably forever — she studies the Spanish language.
Featured image for “Influenza and Audiologists: Mitigating Harm to Life and Wallet”
Jan. 29, 2013

Influenza and Audiologists: Mitigating Harm to Life and Wallet

Holly Hosford-Dunn
Today wraps up a 3-part series on flu vaccination by looking at  private versus public sector efforts to vaccinate and protect, being mindful that we need to protect not only ourselves and our patients, but our professional livelihoods as well.  It’s a perfect blend of Economics and Ethics and, I’d like to point out, Marketing.  If it were me,  I’d put a big
Featured image for “Influenza and Audiologists: In Harm’s Way”
Jan. 21, 2013

Influenza and Audiologists: In Harm’s Way

Holly Hosford-Dunn
Last week’s post ended in high dudgeon at the prospect of hearing professionals violating the Harm Principle by foregoing flu shots.  In the meantime, the flu marches on:  For the second week in a row,  flu deaths exceeded the epidemic threshold; 49.6% of hospital flu admissions were in those 65 and over, 48 states reported the highest category of flu activity
Featured image for “Influenza and Audiologists:  Ethics and Economics Finally Agree on Something”
Jan. 15, 2013

Influenza and Audiologists: Ethics and Economics Finally Agree on Something

Holly Hosford-Dunn
Anyone who picked up a newspaper or turned on the news on January 10th knows that the Centers for Disease Control and Prevention (CDC) is tracking an “overwhelming” influenza outbreak across the US that is thought to grow more vicious before it abates.{{1}}[[1]]At the same time, the CDC has reported the largest outbreak of pertussis in the US in 60 years
Featured image for “Biotechnology Patents for Hearing and Hearing Devices”
Jan. 08, 2013

Biotechnology Patents for Hearing and Hearing Devices

Holly Hosford-Dunn
As promised, here’s an update of interesting hearing technology patents — the list is long but it only encompasses the last two months of 2012.  I think you’ll agree, it looks like a Christmas wish list — hearing aids that tell you how your body’s doing, that find themselves, that test your hearing, that do real-ear; nanotechnology penetrating the tympanic
Featured image for “Hearing Technology Patent Fights”
Jan. 01, 2013

Hearing Technology Patent Fights

Holly Hosford-Dunn
Last year’s top Hearing Economics post  listed some US patents granted in the hearing industry. The list may have stimulated readership, so another cherry-picked list of recent patents will show up in next week’s post and will be updated every few months.  In the meantime, today’s post looks at the exciting afterlife of patents in biotechnology.  Patent Wars   Not
Featured image for “Stayin’ Alive: Drink More Champagne, Avoid Icebergs, Check the Crystal Ball”
Jun. 26, 2012

Stayin’ Alive: Drink More Champagne, Avoid Icebergs, Check the Crystal Ball

Holly Hosford-Dunn
Q:  What were the last words of the Nobel Laureate economist, John Maynard Keynes? A:  “I should have drunk more Champagne.” Right! The next best thing to Champagne is writing these posts and getting readers’ comments.  Here’s a great one from a 1st generation private practice owner and worried mother. Q: Do you think private practice can survive in this
Featured image for “Econ 101:  If Hearing Aids Were Hula Hoops”
Jun. 17, 2012

Econ 101: If Hearing Aids Were Hula Hoops

Holly Hosford-Dunn
This occasional series has taken intrepid readers through economic concepts such as Utility, Decreasing Marginal Benefit and Willingness to Pay — all assumptions underlying the downward-sloping Price/Quantity Demanded curve that we call a Demand Curve.  As those posts illustrated with Jack and Jill’s different Utilities,  analyzing the logic of consumer choices given their limited resources is one way to understand
Featured image for “Intricon part 3: What Does Intricon Make, Anyway?”
Jun. 12, 2012

Intricon part 3: What Does Intricon Make, Anyway?

Holly Hosford-Dunn
This short series has described a tiny company that stayed small and became profitable by specializing in developing and making tiny things for a tiny group of giant customers.  It did this by becoming a “manufacturing OEM”{{1}}[[1]]Original Equipment Manufacturer, as defined in post 2 in this series.[[1]] to several industries, including hearing/audio industries. At this point, we know who IntriCon
Featured image for “IntriCon Corp, part 2:  What, Who, How and Where?”
Jun. 05, 2012

IntriCon Corp, part 2: What, Who, How and Where?

Holly Hosford-Dunn
 WHAT is ItriCon?    IntriCon Corp describes itself as a “manufacturing OEM.” For the uninitiated (like me) OME stands for “Original Equipment Manufacturer.”  An OEM manufactures parts and finished products which it sells to other companies, which in turn use the parts and sell the purchased products under their own brand names.  IntriCon further describes itself as an OEM “dependent
Featured image for “The Tiny Company That Could: Intricon”
May. 29, 2012

The Tiny Company That Could: Intricon

Holly Hosford-Dunn
A year ago, odds are low that the name “IntriCon” was tripping off the tongues of most Audiologists.  That may not have changed much in the past year, but it is worth knowing about Intricon Corp., the “tiny” company that is the little engine that could and did:  it is the manufacturing force driving big UHC’s subsidiary,  Hi HealthInnovations.  I’ll